AMSTERDAM, the Netherlands, May 12, 2016 -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced that its management will be presenting at the below listed investor conferences in May and June, 2016.
- Piper Jaffray GenomeRx Symposium
Venue: The InterContinental New York Barclay Hotel, New York City
Title: Getting to the Heart (& Muscle) of the Gene Therapy Matter
Presenter: Christian Meyer, Chief Medical Officer
Date and Time: May 17, 2016: 10.40 AM EDT
- 2016 UBS Global Healthcare Conference
Venue: Grand Hyatt New York Hotel, New York City
Presenter: Daniel Soland, Chief Executive Officer
Date and Time: May 24, 2016: 08.00 AM EDT
Webcast: A webcast of the presentation will be available through the details listed below
- Jefferies 2016 Healthcare Conference
Venue: Grand Hyatt New York Hotel, New York City
Presenter: Matt Kapusta, Chief Financial Officer
Date and Time: June 10, 2016: 11.00 AM EDT
The webcast, including a slide presentation at the 2016 UBS Global Healthcare Conference, can be accessed through the following link: https://cc.talkpoint.com/ubsx001/052316a_ae/?entity=47_SI2EH82 or by accessing the link displayed in the "Events" section on the "Media" page of the uniQure website at: http://www.uniqure.com/news/calendar-of-events/. The replay of the webcast will be available one hour after the conclusion of the live event and archived on the uniQure website for at least 30 days following the webcast.
About uniQure
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases. www.uniQure.com
CONTACT: uniQure:
Eva Mulder
Direct : +31 20 240 6103
Main: +31 20 240 6000
[email protected]
Media inquiries:
Gretchen Schweitzer or Stephanie May
MacDougall Biomedical Communications
Direct: +49 172 861 8540 or +49 175 5711562
Main: +49 89 2424 3494 or +1 781 235 3060
[email protected]


SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028 



